-hybridized carbon atom between the two aromatic rings and 2) the two aromatic moieties in angulated orientation are optimal for BPA's effectiveness. Since BPA highly pollutes the environment and is incorporated into the human organism, our data may provide a basis for future studies relevant for human health and development.
Introduction
Bisphenol A (BPA) is a chemical that is extensively used (.3.8 million tons/yr worldwide) to produce polycarbonate plastic and epoxy resins. Both synthetics are manufactured into highly diverse mass products such as optical media (CD and DVD), protective coatings inside metal food containers, baby bottles, thermal paper, composites, and sealants in dentistry and medical tubing (for review see Vandenberg et al., 2007; Dekant and Völkel, 2008) . BPA is an environmental pollutant that is incorporated into living organisms (for review see von Goetz et al., 2010) . Common routes of BPA exposure in humans are oral intake, respiration, and dermal absorption (Braunrath, 2005; Biedermann et al., 2010; Loganathan and Kannan, 2011) . Detectable levels of BPA were found in over 90% of people living in industrialized countries due most likely to chronic exposure (Calafat et al., 2005; Calafat et al., 2008 ; see also He et al., 2009 ). BPA's adverse effects on human health and the ecosphere are being increasingly recognized (for review see Chapin et al., 2008) .
Numerous studies have shown that BPA influences a wide range of physiologic functions (for review see Rubin, 2011) . It is very well documented that BPA and various related compounds bind to hormone receptors and influence multiple endocrine pathways Okada et al., 2008; Swedenborg et al., 2009; Riu et al., 2011; Soriano et al., 2012) . Beyond this, recent studies provide evidence that BPA can directly interact with biologically active proteins such as enzymes and ion channels (Hiroi et al., 2006; Asano et al., 2010; Hashimoto et al., 2012; O'Reilly et al., 2012; Pandey and Deshpande, 2012) . Protein disulfide isomerase (PDI) has been isolated as a binding protein of BPA in the rat brain. BPA binds to different domains of protein disulfide isomerase with K D values in the range of 10 26 to 10 23 molar (Hashimoto et al., 2012) . A rapid and reversible increase of large conductance Ca 21 /voltage-sensitive K 1 (Maxi-K) channel activity by BPA (10-100 mM) has been shown in human and canine coronary smooth muscle cells as well as in AD-293-cells expressing the recombinant form of the channel (Asano dx.doi.org/10.1124/mol.112.081372. ABBREVIATIONS: 2,29-DPP, 1,19-(1-methylethylidene)bisbenzene; 49-CP, 4-(1-methyl-1-phenylethyl)phenol; 49-TAP, 4-(1,1-dimethylpropyl) phenol; 4, 4, biphenol, (1, BPA, 4, diphenol (also bisphenol A); BPAB, 4,49-(2,2-butanediyl)diphenol; BPAF, 4, 1, 1, 3, 3, BPE, 4, BPF, 4, BPM, 4, diphenol; BPP, 4,49-(1,4-phenylenediisopropylidene)diphenol; BPS, 4,49-sulfonyldiphenol; CER, concentration-effect relationship; DRG, dorsal root ganglion; DMEM, Dulbecco9s modified Eagle9s medium; ERR-g, estrogen-related receptor-g; HEK, human embryonic kidney; HVA, high voltage-activated; LVA, low voltage-activated; PDI, protein disulfide isomerase; TBBA, 4,49-(1-methylethylidene)bis-2,6-dibromophenol (also tetrabromobisphenol A); TMBPA, 4,49-isopropylidenebis(2,6-dimethylphenol). et al., 2010) . Furthermore, inhibitory effects of BPA in the micromolar range have been reported for mouse neuronal (Wang et al., 2011) and human cardiac Na 1 channels (O'Reilly et al., 2012) . In the latter case it has been shown that BPA directly binds to the channel protein at the local anesthetic receptor site.
In the present study we have characterized the interaction of BPA and several of its related compounds with voltageactivated Ca 21 channels. This family of channels can be divided into subtypes that are expressed in different cells of the body (for review see Catterall et al., 2005) . The different types of voltage-activated Ca 21 channels play key roles in various physiologic and pathophysiological processes such as excitation-contraction coupling, synaptic transmission, hormone release, gene expression, and cell death and differentiation (for review see Catterall, 2011 
Material and Methods
Cells and Cell Culture. Endocrine rat pituitary tumor cells (GH 3 line; DSMZ, Braunschweig, Germany) were grown on 100 mm culture dishes (Becton Labware, Franklin Lakes, NJ) in Ham F10 medium supplemented with 15% horse serum, 2.5% fetal calf serum, 1% penicillin-streptomycin, and 2 mM glutamine. Two to seven days before electrophysiological recordings, cells were harvested with trypsin or accutase (PAA, Pasching, Austria) and plated on poly-L-lysine-coated (Sigma-Aldrich, Taufkirchen, Germany) 6-mm glass coverslips in P.neural medium (P.Glia, Rheinbach, Germany) and maintained in humidified atmosphere (37°C). Cells were used for electrophysiological recordings within the following 48 hours.
Dorsal root ganglion (DRG) neurons were excised from decapitated 4-to 14-day-old male or female (ratio ∼1:1) mice (C57BL/6) and incubated for 25 6 5 minute in extracellular solution consisting of 124 mM NaCl, 2.5 mM KCl, 26 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 1.3 mM MgSO 4 , 2 mM CaCl 2 , 10 mM D-glucose, pH 7.35, gassed with carbogen (95% O 2 , 5% CO 2 ) containing 0.04% collagenase and 0.025% trypsin type I (Roche, Mannheim, Germany) at 37°C. Digestion was stopped by resuspending the tissue in culture medium: Dulbecco's modified Eagle's medium (DMEM)/F12 (1:1) (Invitrogen, Mannheim, Germany) supplemented with 10% fetal bovine serum, penicillin (100 IU/ml) and streptomycin (100 IU/ml), and 2 mM L-glutamine (all Invitrogen). Tissue was triturated mechanically by vigorously shaking and centrifuged at 160g for 5 minutes after filtration. Pellet was resuspended in culture medium and cells were plated on poly-Llysine-coated glass coverslips and kept in humidified atmosphere (37°C, 95% air, 5% CO 2 ). Cells of medium size were used for electrophysiological recordings within the following 12 hours. All animal experiments were conducted in accordance with the guidelines of the Animal Care Committee of the University of Bonn.
Cardiac myocytes were isolated from male or female (ratio ∼1:1) mice (C57BL/6) as described previously (Linz and Meyer, 2000) . Briefly, hearts were removed and cardiopleged in cold Tyrode solution containing 135 mM NaCl, 4 mM KCl, 1 mM MgCl 2 (H 2 O) 6 , 2 mM HEPES, 2.6 mM EGTA, pH 7.4. The heart was rapidly attached to a Langendorff apparatus and perfused with the Tyrode solution described above (37°C) followed by a high-potassium solution (4 mM NaCl, 10 mM KCl, 1 mM MgCl 2 , 0.2 mM CaCl 2 , 130 mM Kglutamate). For digestion 200 IU/ml trypsin type I (Sigma) and 0.4 mg/ml collagenase type II (Sigma-Aldrich) were added. The ventricles were cut down, chunked and allowed to settle in oxygenated Tyrode solution containing 135 mM NaCl, 4 mM KCl, 1 mM MgCl 2 , 2 mM HEPES, 1.8 mM CaCl 2 , 1 mM BSA, and 16.6 mg/l trypsin inhibitor. The solution was filtered through a 125-mm nylon mesh, centrifuged briefly, and the pellet was resuspended in fresh Tyrode solution. Cells were plated on poly-L-lysine-coated glass coverslips and recordings were performed 1-8 hours after plating.
HEK293 cells stably expressing human a 1E and b 3 Ca 21 channelsubunits were kindly provided by T. Schneider, University of Cologne (Nakashima et al., 1998) . Cells were maintained in DMEM supplemented with penicillin (100 IU/ml), streptomycin (100 mg/ml) (Invitrogen, Darmstadt, Germany), and 10% fetal bovine serum. Geneticin (0.5 mg/ml) and hygromycin (0.2 mg/ml) were used for selection of a 1E -and b 3 -subunit expression, respectively. Cells were plated on poly-L-lysine-coated glass coverslips and used within 24-48 hours after plating for recordings.
Electrophysiological Recordings. Ca 21 and/or Ba 21 currents were recorded in the whole-cell configuration of the patch-clamp technique using an EPC9 patch-clamp amplifier and the PULSE software (HEKA Electronic, Lambrecht, Germany). Data were filtered and digitized at 3 and 10 kHz, respectively, and stored on hard disk. For recordings of tail currents the sampling rate was 100 kHz. In ventricular cardiac myocytes Ca v 1.2 L-type Ca 21 channels constitute the major pathway for high voltage-activated (HVA) Ca 21 currents (Bers and Perez-Reyes, 1999) . Ba 21 (2 mM) currents through these channels were elicited by voltage ramps (200-millisecond) from -50 mV to 170 mV. In mouse DRG neurons Ca 21 currents through T-type Ca 21 channels were evoked by depolarizations (100-millisecond) from -70 mV to -20 mV using Ca 21 (10 mM) as charge carrier. Currents through N-type Ca 21 channels were elicited by voltage ramps (100-millisecond) from -70 mV to 150 mV using Ba 21 (1 mM) as charge carrier. Currents were recorded in the presence of nifedipine (10 mM) and v-agatoxin-TK (0.2 mM) to eliminate contribution from L-and P/ Q-type Ca 21 channels, respectively. The internal solution of the recording electrodes contained: 160 mM cesium-aspartate, 10 mM EGTA, 2 mM MgATP, 20 mM phosphocreatine, 0.2 mM Na 2 GTP, 20 mM HEPES (pH 7.3, 290-300 mOsmol/l). Filled electrodes had resistances between 1.5 and 4 MV. The extracellular solution contained: 160 mM TEA-Br, 3 mM KCl, BaCl 2, or CaCl 2 , 1 mM NaHCO 3 , 1 mM MgCl 2 , 10 mM HEPES, and 4 mM glucose (pH 7.4, 300-310 mOsmol/l). The final concentrations of Ba 21 and Ca 21 are indicated throughout the text. All recordings were performed at room temperature (20-23°C).
The recording chamber was continuously perfused at a rate of 1 ml/ min. The bath volume was exchanged every 20 seconds. Drugs were applied in external solution using a fast-pressure-application system (DAD-VM Superfusion System; ALA Scientific Instruments, Farmingdale, NY). The tip of the application pipette (diameter 100 mm) was positioned within 100 mm off the cells and solution exchange was obtained within ∼20 milliseconds.
Drugs. Bisphenol A and the related compounds were purchased from Alfa Aesar (Karlsruhe, Germany) or Sigma-Aldrich (Taufkirchen, Germany). Stock solutions of the drugs were prepared in ethanol at a concentration of 200 mM and stored at room temperature. All toxins were obtained from Tocris Biosciences (Wiesbaden, Germany) and stock solutions were prepared in distilled water. Application solutions were freshly prepared from stock solution. The highest final concentration of the solvent ethanol was 0.15% which did not affect voltage-activated Ca 21 channels. All other chemicals were obtained from Sigma-Aldrich.
Data Analysis and Statistics. The analysis of the whole-cell recordings was carried out offline using PulseFit (HEKA, Germany) or IGOR software (Wavemetrics, Lake Oswego, OR). Data fitting and statistical analysis were performed using PRISM 5.0 (GraphPad Software Inc., San Diego, CA). EC 50 values and Hill slopes were determined by fitting data points to a logistic function. Chargevoltage relationships were fitted by an equation in the form y 5
, with G max 5 maximum conductance, V 1/2 5 half-maximal activation, V test 5 test potential, V rev 5 reversal potential, and k 5 slope factor. Data for m ' and h ' were fitted to a Boltzmann function
Time course for recovery from inactivation was Fig. 1 . BPA inhibits HVA whole-cell Ba 2+ currents in GH 3 cells. (A) Concentration-dependent inhibition of Ba 2+ (5 mM) currents by BPA. Currents were elicited by depolarizing steps (50-millisecond) to 0 mV at 0.1 Hz. Increasing concentrations of BPA (as indicated) were successively applied for 40 seconds. Note that the current recovered completely upon washout of 100 mM BPA. (B) Time-course of current inhibition by BPA (100 mM). Currents were evoked by brief depolarizing steps (15-millisecond) to 0 mV at 1 Hz. Current amplitudes were measured 10 milliseconds after beginning of the depolarization and current inhibition (%) was plotted versus time. Application of BPA is indicated by the horizontal bar. (C) Charge-voltage relationship (C-V) for total Ba 2+ currents for control (circles) and in the presence of 70 mM BPA (squares; n = 3). Data points represent the charge transferred for each current pulse (100-millisecond). Solid lines represent fit of data points to the equation given in Materials and Methods. BPA did not significantly affect values for half-maximum activation (m ' ; control: -10.3 6 0.9 mV, BPA: -4.9 6 2.7 mV; P . 0.07). Inset shows fractional block for the data from Fig. 1C . (D1) Summary of pharmacological dissection of HVA Ba 2+ currents using v-conotoxin GVIA (1.5 mM), v-conotoxin MVIIC (1.5 mM), nifedipine (10 mM) or nifedipine plus v-conotoxin MVIIC. Current inhibition of normalized peak currents is shown in percent (n in parentheses). (D2) Contribution of the different Ca 2+ channel types to the total Ba 2+ current. (E1) Normalized peak current inhibition (%) of total Ba 2+ current by BPA (70 mM). (E2) Inhibition of pharmacologically dissected Ba 2+ current fractions by BPA (70 mM; n in parentheses; drug concentrations as in D1). (F) CER for BPA-mediated inhibition of total (filled symbols) or P/Q-(+R-) type HVA currents (open symbols). CERs were obtained by plotting normalized peak current inhibition (%) against BPA concentration. Data points were fitted to a logistic function yielding an EC 50 of 26 6 1.1 and 32 6 1.9 mM for total and P/Q-(+R-) type HVA currents, respectively (n = 3-9; see Table 1 ).
fitted by a double exponential function. The data in the manuscript are presented as mean 6 standard error unless stated otherwise. Statistical analysis was performed using Students t test or one-way analysis of variance and Tukey's post-test. Differences with P value ,0.05 were regarded as significant and levels of significance are indicated by asterisks (*** P,0.001, ** P,0.01, * P,0.05).
Results

Inhibition of High Voltage-Activated Ca
21 Channels by BPA in GH 3 Cells. GH 3 cells used in our experiments express essentially HVA Ca 21 channels. BPA was applied extracellularly to single cells at micromolar concentrations using a fast application system (see Materials and Methods). Fig. 1A shows the effect of BPA on Ba 21 currents (5 mM) elicited by depolarizing voltage steps (50-millisecond) to 0 mV at 0.1 Hz for three different concentrations. Each concentration (starting with 10 mM) was applied for 40 seconds during which maximal inhibition was achieved. The current inhibition was almost fully reversible and currents recovered completely within about 1 minute upon washout of BPA. Similar results were obtained with Ca 21 (10 mM) as charge carrier. Note that internal perfusion with BPA even at high concentrations (100 mM) was ineffective (unpublished data). Fig. 1B illustrates the time course of Ca 21 channel block by 100 mM BPA and of its washout when brief depolarizing steps (15-millisecond) to 0 mV were applied at 1 Hz. The finding that the amount of block by BPA did not vary with different stimulation frequencies (0.1 and 1 Hz) implies that the block is not use-dependent (for a more detailed analysis see R-type Ca 21 channels below).
In further experiments the effect of BPA (70 mM) was studied at different depolarizing voltages. The charge transferred by an individual Ba 21 current was determined from the area under the current curves. Fig. 1C shows the chargevoltage relationship obtained in the presence and absence of BPA. While charge transfer was significantly reduced there was no significant shift in the charge-voltage curve in the presence of BPA. The mean value of the block at different membrane potentials was calculated from corresponding data points and plotted against voltage (fractional block, see inset). The degree of block did not vary significantly within the voltage range tested (P 5 0.92; n 5 3).
To analyze the blocking action of BPA in more detail total currents were pharmacologically dissected using nifedepine and/or v-conotoxins. As illustrated in Fig. 1D1 the application of v-conotoxin GVIA (1.5 mM) was ineffective, indicating that N-type channels did not contribute to the total current. 2+ channels in cardiac myocytes. CERs were obtained by plotting normalized peak current inhibition (%) against BPA concentration. Values for EC 50 and Hill slope were obtained by fitting the data points to a logistic function. EC 50 values for N-, T-, and L-type channels were 35 6 1.3 mM, 26 6 1.2 mM, and 35 6 1.3 mM, respectively (n = 3-8; see Table 1 ). For isolation of HVA and LVA Ca 2+ channels in DRG neurons see Materials and Methods. 
Downloaded from
Application of nifedepine (10 mM), which blocks L-type Ca 21 channels, resulted in a 52 6 3.9% (n 5 6) reduction of the total current. Block of P/Q-type Ca 21 channels by v-conotoxin MVIIC (1.5 mM) reduced the total current by 30 6 0.9% (n 5 7). A small current fraction (probably R-type) of 17 6 2.0% (n 5 3) of the total current was resistant to both nifedepine and v-conotoxin MVIIC. Figure 1D2 illustrates the contribution of the different HVA Ca 21 channel types to the total current. In the presence of BPA (70 mM) the total Ba 21 current was inhibited by 74.2 6 2.6% (n 5 7; Fig. 1E1 ). Figure 1E2 shows that inhibition of the current components remaining after nifedepine and/or v-conotoxin MVIIC application did not significantly differ from inhibition of the total current by BPA (P . 0.7 between the four columns). These findings indicate that BPA does not discriminate between the different HVA Ca 21 channel types and blocks L-, P/Q-, and probably R-type Ca 21 channels to the same extent. Figure 1F illustrates the concentration-effect relationship for total Ba 21 currents and currents in the presence of nifedepine. The potency of BPA to inhibit currents is similar for both curves (see Table 1 ). This supports our findings that BPA does not distinguish between the different HVA channel types.
Inhibition of High and Low Voltage-Activated Ca
21
Channels by BPA in DRG Neurons. In DRG neurons Ntype Ca 21 channels are predominant (Fig. 2A2) , as indicated by the finding that 78 6 0.6% (n 5 3) of the total Ba 21 currents were blocked by the application of v-conotoxin GVIA (500 nM) (Fig. 2A1) . Application of nifedipine (10 mM) reduced the current by 15 6 1.7%. Application of agatoxin-TK (200 nM), a P/Q-type Ca 21 -channel blocker, was ineffective. A small current fraction (∼6%) was resistant to the blockers applied and was presumably through R-type Ca 21 channels (Fig.  2A2) . Dose-dependent inhibition of N-(1R-) type channels by BPA was studied in the presence of nifedipine and agatoxin TK (Fig. 2B) (Bers and Perez-Reyes, 1999) . BPA inhibited these Ca 21 channels in a concentration-dependent manner with an EC 50 of 35 6 1.3 mM (Fig. 2D) . As in endocrine and neuronal cells, the 2+ currents by BPA is not dependent on resting membrane potential. Currents were evoked from a membrane potential of either -70 mV (filled circles) or -100 mV (open circles). Normalized peak current inhibition (%) was plotted against BPA concentration and data points were fitted to a logistic function (at -70 mV: EC 50 26 6 1.04 mM, Hill slope = 1.19 6 0.06; at -100 mV: EC 50 32 6 1.03 mM, Hill slope = 1.16 6 0.06; n = 3-9). Figure 3A shows a family of Ba 21 (15 mM) currents elicited by depolarizing steps (100-millisecond) to voltages between -10 and 140 mV. BPA (35 mM; middle panel) reversibly inhibited currents and nearly full recovery from current inhibition was observed within 2 minutes upon washout (Fig. 3A, right panel) . Small reductions in current amplitudes after washout were most likely due to current rundown during internal perfusion. In some cells full recovery could be obtained. To test for use-dependence of the block, depolarizing steps (15-millisecond) to 0 mV were applied at 0.1, 1, and 10 Hz. The amount of block obtained by BPA (35 mM) at each frequency did not vary significantly (P 5 0.88; unpublished data; see also Fig. 1, A and B) . This was also the case when the frequency was changed to 10 Hz after block had reached its equilibrium at 0.1 or 1 Hz. Figure 3B illustrates the charge transferred by Ba 21 ions through R-type Ca 21 channels at different depolarizing voltages for control and in the presence of 35 mM BPA (C-V relationship). Inhibition of Ba 21 currents through R-type Ca 21 channels by BPA was concentration-dependent and occurred with an EC 50 of 26 6 1 mM (Fig. 3C) .
To test whether binding of BPA is state-dependent, holding potential was shifted from -70 mV to -100 mV where almost all of the channels are in the resting state (Fig. 4A) . As we did not observe any significant change in potency ( Fig. 3C ; EC 50 32 6 1 mM; P 5 0.66), this finding strongly suggests that BPA binds to the channel in its resting state.
As illustrated in Fig. 3A current activation and inactivation kinetics were hardly affected by BPA. In further experiments we determined steady state activation and inactivation under control conditions and in the presence of 35 mM BPA (Fig. 4A ) and found that neither the steady state activation nor the inactivation curves were significantly affected by BPA. Taken together these findings provide additional evidence that BPA binds to and stabilizes the resting state of the channel. Further support comes from the observation that neither recovery from inactivation ( Fig. 4B ; P 5 0.824) nor deactivation kinetics ( Fig. 4C ; P 5 0.73) were significantly changed by BPA.
To exert its action BPA has to be present for a certain time period (preapplication time) before current activation. When preapplied for 100 milliseconds BPA (70 mM) started to become effective and approached its maximal inhibitory effect after 10 seconds of preapplication (Fig. 5A) . When block was brought to equilibrium by prolonged preapplication (3 minutes) of BPA (35 mM) before a long-lasting depolarizing step (1-second) was applied, we observed only a reduction in current amplitude and no change in the rate of current decay (Fig. 5, C and D ). These findings demonstrate that BPA is not blocking open channels. Further support for these results came from the observation that BPA did not affect either current amplitude or current kinetics when applied during depolarizing pulses with channels in the open state (Fig. 5B) . 
and steady-state inactivation (h ' ) are not affected by BPA (control, circles; BPA, squares). To determine activation curves membrane potential was stepped for 1 second from -70 mV to -100 mV followed by depolarizing steps (10-millisecond) to potentials between -100 mV and +70 mV. Tail currents were recorded on repolarization to -70 mV. Normalized tailcurrent amplitudes were plotted versus test potential. Steady state inactivation was expressed as the ratio of two test pulses to +20 mV, separated by a 2-second inactivating pulse to membrane potentials between -100 and +5 mV. Normalized peak current amplitudes were plotted against membrane potential and data points were fitted to a Boltzmann function (m ' : V 0.5 = 5.0 6 1.1 mV, k = 12.5 and V 0.5 = 5.7 6 1.0 mV, k = 11.3 (n = 6); h ' : V 0.5 = -73 6 1.8 mV, k = 11.6 and V 0.5 = -72.8 6 1.2 mV, k = 12.1 (n = 4) for control and 35 mM BPA, respectively). (B) The time course for recovery from inactivation was obtained using a double pulse protocol (see inset) and is plotted as the ratio of peak current amplitudes (%) against the interpulse interval. Recovery from inactivation was not significantly different in the presence of BPA (35 mM; P = 0.824; n = 4-9). (C) BPA (70 mM) does not influence tail-current kinetics. Tail currents were measured on repolarization to -80 mV following depolarizing steps (10-millisecond) from -50 mV to +80 mV in the presence or absence of BPA. Inset: Normalized tail currents of Fig. 4C show similar current decay kinetics. The tail-current decay could be fitted to a single exponential function with a time constant (t) of 366 6 30 microseconds (control) and 383 6 33 microseconds (BPA), respectively (fit range is indicated by vertical lines; P = 0.73; n = 3).
Even concentrations as high as 300 mM did not produce any current inhibition.
To test for a possible involvement of intracellular signaling pathways in BPA's action, modulators of G proteins and protein kinases A and C were applied (Fig. 6) . Irreversible activation or inhibition of G proteins by adding guanosine 59-O-(3-thiotriphosphate) (20 mM) or GDPbS (1 mM) to the internal perfusion solution had no significant effect on the blocking action of BPA. Neither was BPA's action affected by the inhibition of protein kinases A and C by H-89 (10 mM) and GÖ-6983 (10 mM), respectively. These modulators were applied extracellularly for up to 10 minutes. It is noteworthy that GÖ-6983 itself inhibited Ca 21 channels to about 77.6 6 1.8% (n 5 3) after 4-5 minute. Similar effects of GÖ-6983 have been previously described for L-type Ca 21 channels (Welling et al., 2005) . BPA was always applied after the inhibitory effect of GÖ-6983 had reached its maximum.
Several reports have suggested or demonstrated that hormones are able to modulate Ca 21 channels by direct interaction (for review see Boonyaratanakornkit and Edwards, 2007) . In particular 17b-estradiol has been shown to rapidly and reversibly reduce cardiovascular L-type Ca 21 channels at micromolar concentrations (Jiang et al., 1992; Nakajima et al., 1995; Meyer et al., 1998 ). Since we found that BPA inhibited L-type Ca 21 channels in cardiomyocytes (Fig. 2D ) we wondered if it shares a common binding site on Ca 21 channels with E 2 . Indeed E 2 (100 mM) also reduced R-type Ca 21 channels rapidly and reversibly by 40.7 6 2.3% (Fig. 7A ).
At this concentration the E 2 -mediated inhibition was near saturation (Fig. 7B ) but was significantly smaller than that observed with BPA (more than 80%) at the same concentration (Fig. 7, A and B) . Similar results were obtained with total currents in GH 3 cells (unpublished data). BPA's action requires binding to the resting state of the R-type Ca 2+ channel. When BPA (70 mM) was applied before the onset of a depolarizing step (100-millisecond) to 0 mV (preapplication) its effectiveness increased with preapplication time. (A) Bars represent normalized peak current amplitude inhibition (%) after different preapplication times. After 10 seconds, inhibition was almost complete and did not increase significantly with longer preapplication times (P . 0.05 for 10 seconds versus 20 seconds and 10 seconds versus 40 seconds, n = 3-4). (B) BPA was completely ineffective when applied after the onset of the depolarizing step. Representative current traces shown for control and coapplication of BPA. Application time is indicated by the horizontal bar. (C) Current traces were elicited by 1-second depolarizing steps to -10 mV and were recorded before (control) and 3 minutes after incubation with BPA (35 mM). No channel openings were elicited during the incubation period. Note that the block by BPA was fully developed after incubation and that Ca 2+ channel kinetics were not altered. Current decay was fitted to a double exponential function. The time constants for control and BPA were t 1 : 63 6 9 milliseconds and 43 6 3.6 milliseconds, t 2 : 299 6 58 milliseconds and 261 6 41 milliseconds, respectively (t 1 : P = 0.8; t 2 : P = 0.6; n = 5). (D) Normalized traces from (C). ***P ,0.001, *P,0.05 Fig. 6 . BPA's action on R-type Ca 21 channels in HEK293 cells is independent of intracellular signaling pathways. The modulators of intracellular signaling pathways GTPgS [guanosine 59-O-(3-thiotriphosphate)] (20 mM), GDPbS (1 mM) (G proteins), GÖ-6983 (10 mM) (protein kinase C inhibitor) and H-89 (10 mM) (protein kinase A inhibitor) had no effect on BPA (70 mM; control)-induced Ba 2+ current inhibition. G protein modulators were added to the internal solution and allowed to diffuse into the cell for 10 minutes before current recording started. Protein kinase C and protein kinase A inhibitors were applied via bath for up to 10 minutes. Currents were elicited by voltage ramps ranging from -70 mV to +50 mV for 50 milliseconds every 15 seconds. (P . 0.35; n = 3-10)
In case of a common binding site one would expect that under these conditions the combination of the two compounds is less effective than BPA alone. This, however, was not observed (Fig. 7, A and B) . On the contrary, the combination of the two compounds was slightly but significantly more effective (BPA, 81.5 6 1.3%, n 5 14; BPA 1 E 2 , 85.6. 6 1.3%, n 5 12; P , 0.05).
Effect of BPA and Related Compounds on Ca 21 Channels in GH 3 Cells. To study the structure-activity relationship of bisphenol A and related substances, compounds with 1) different bridging structures between the two phenolic rings (e.g., BPAF, BPF, 4,49-HBP), 2) different aromatic substitution patterns (49-CP, 2,29-DPP, TMBPA), and 3) different sterically demanding structure moieties (49-TBP, 49-TAP, BPM, BPP) were investigated in GH 3 cells (Fig.  8) . Table 2 summarizes the effect of the various phenolic and bisphenolic compounds on HVA Ba 21 currents in GH 3 cells in relation to BPA.
TBBA, one of the most abundantly produced halogenated flame retardants, effectively inhibited Ba 21 currents at 100 mM concentration. As shown in Fig. 8A , TBBA was slightly but significantly less effective in blocking Ca 21 channels than BPA (Table 2 ). In contrast, BPS, another high production monomer, had no significant effect at this high concentration (Table 2) .
Comparing the effects of BPA, 49-CP, 2,29-DPP, TBBA, and TMBPA, the aromatic substitution pattern strongly influences the ability to inhibit Ca 21 channels. The chemical structure of BPA is composed of two methyl groups and two phenol moieties on the central sp 3 -hybridized carbon atom. 49-CP, which lacks one phenol-hydroxyl group, was about half as active as BPA. 2,29-DPP, lacking both of the phenol-hydroxyl groups, was ineffective (,20%). Furthermore, four aromatic methyl groups at meta-position (TMBPA) decrease the activity, whereas TBBA with four bromines as substituents was almost as active as BPA. Obviously, an aromatic substituent like bromine with a positive mesomeric effect and a predominant negative inductive effect supports the ability of meta-substituted compound to inhibit Ca 21 channels by reducing the electron density of p-systems.
In addition, the double-methylated sp 3 -hybridized carbon atom present in BPA and TBBA, which bridges the two phenol rings, is optimal for the ability of the compounds to inhibit Ca 21 channels. In fact, successive removal of the methyl groups revealed less effective bisphenols (BPE, BPF). Remarkably, BPAF, where the methyl groups are replaced with trifluoromethyl moieties was twice as potent as BPA (EC 50 5 13 6 1.15 mM, data not shown). BPAB, which has a bulky bridging structure, (R-C(CH 3 )(CH 2 CH 3 )-R), was almost equally effective compared with BPA. Furthermore, sp 2 -hybridization of this carbon atom or introduction of different bridging structures led to bisphenols that were ineffective (494-HBP, BPS). It is interesting to note, that biphenol [(1,1'-biphenyl)-4,4'-diol] did not show any activity, which again confirms that a sp 3 -hybridized carbon atom bridging the aromatic rings is essential for the blocking effect on Ca 21 channels.
Apparently, two aromatic ring moieties in angulated orientation are required for Ca 21 channel block. The blocking activity of compounds lacking one of the aromatic rings (49-TBP; 49-TAP) was much less pronounced than that of BPA ( Fig. 8B ; Table 2 ). Finally, the ability to inhibit Ca 21 channels by sterically demanding bisphenols like BPM strongly depends on the spatial orientation of all aromatic rings. In BPM, which blocked voltage-activated Ca 21 channels by ∼70%, these rings are arranged in line. In case the molecule is angulated as in BPP, where one of the aromatic rings is rotated almost through 90°to form a right-angled structure, inhibition of voltage-activated Ca 21 channels was negligible.
Discussion
In this study we present evidence that BPA interacts with voltage-activated Ca 21 channels as inhibitory ligand. BPA's efficacy as inhibitor is comparable to that of polyvalent cations such as cadmium, cobalt, and manganese (Carbone and Swandulla, 1989) . Pharmacological experiments with specific organic blockers (nifedepine and v-conotoxins) for the different Ca 21 channel types showed that BPA affects all subtypes studied here (L-, N-, P/Q-, R-, T-type) to the same extent. Detailed analysis of biophysical properties on human R-type channels revealed that channel kinetics (activation, inactivation, and deactivation) and steady-state characteristics (activation and inactivation) were not significantly altered by BPA.
In summary, our biophysical and pharmacological analysis strongly suggests that BPA exerts its action by binding to the channels in their resting state. This is supported by the findings that 1) the amount of block is independent of the currents by E 2, BPA, or both at the concentrations indicated (mM). Inhibition of mean peak current in (%) was E 2 (30 mM): 19.1 6 1.5%, n = 4; E 2 (100 mM): 40.7 6 2.3%, n = 14; E 2 (200 mM): 51.8 6 2.7%, n = 4. Significant differences are indicated above the columns (*P , 0.05, ***P , 0.001; n = 4-15).
frequency and duration of current activation, 2) the current kinetics are not altered, 3) there is no shift in the steady state inactivation curve. Furthermore, our findings suggest that the binding site is located at the extracellular part of the poreforming subunit. BPA as a highly lipophilic substance might reach a binding site at the transmembranal part of the channel protein. However, when applied intracellularly BPA was ineffective.
Direct evidence that BPA interacts with a specific binding site comes from the analysis of structurally related phenol and bisphenol derivatives. To be effective the molecules have to meet certain structural requirements. From the binding motive of a double-methylated or double-trifluoromethylated sp 3 -hybridized carbon atom flanked by two phenol moieties in angulated orientation, one can strongly assume a specific binding site at the various Ca 21 channels that interacts with effective compounds. The ability of BPA and related compounds to specifically interact with proteins has already been demonstrated for certain hormone receptors (Matsushima et al., 2007) . Similar findings were described for BPA estrogen-related receptor-g (ERR-g) interactions. Whereas BPA (IC 50 5 9.78 6 0.87 nM) showed a high binding affinity to ERR-g, BPF was approx. (IC 50 5 131 6 17.9 nM) 16-fold less potent, which clearly demonstrated the importance of the double-methylated central carbon atom for ERR-g interactions. Okada et al., 2008) . In BPAF the two methyl groups are replaced by two electron-rich trifluoromethyl moieties, which reduced the binding affinity to the ERR-g considerably by a factor of 35. In contrast, the inhibitory effect on Ca 21 channels was more pronounced with BPAF compared with BPA. Furthermore, 2,29-DPP lacking both of the phenol-hydroxyl groups did not show any ERR-g Fig. 8 . Structural requirements of BPA for inhibition of HVA Ca 2+ channels in GH 3 cells. Comparison of BPA to various bisphenolic (A) and phenolic (B) compounds. Ba 2+ currents were elicited by applying voltage ramps (100-millisecond) from -70 mV to +50 mV. Compounds (100 mM) were applied 15 seconds before the onset of the voltage ramps and washed out immediately after return to the holding potential. Onset of the block was fast and recovery was complete for all compounds applied except for BPM and BPP. Bars illustrate normalized peak current amplitude reduction (%) induced by the various compounds (systematic names for compounds and statistical values are given in Table 2 ). Although there are some matches in the compound's activity profiles for ERR-g and Ca 21 channels, we do not assume that the two binding sites for BPA possess major structural similarities on the two proteins.
Since BPA and several of its related compounds are environmental pollutants that can be incorporated into the human organism, exposure to these chemicals may cause serious health problems. Urinary levels of BPA have recently been associated with chronic diseases, including heart disease, diabetes, as well as neurobehavioral changes in toddlers (Lang et al., 2008; Melzer et al., 2010; Sathyanarayana et al., 2011) .
The Environmental Protection Agency considers a safe level of exposure to be 50 mg/kg of body weight per day (U.S. EPA, 2010) . Recent experiments with primates, however, indicate that human exposure may be much higher than previously assumed (Taylor et al., 2011) . Under certain conditions exposure to BPA may exceed putative safe levels. This could be the case in manufacturing facilities. Indeed recent studies have shown that workers in epoxy resin factories can have approximately 1000 times higher urinary BPA concentrations compared with control groups (He et al., 2009; Melzer et al., 2010; Wang et al., 2012) . The highest levels measured were almost up to 10 mM (Wang et al., 2012) , which is within the effective concentration range of Ca 21 channels block by BPA. High exposure to BPA has also been reported for patients, particularly premature infants undergoing intensive medical care treatment (Calafat et al., 2009) .
In general the incorporation of the lipid-soluble compound BPA in certain body compartments is not very well studied and it is conceivable that BPA could accumulate to micromolar concentrations in the human body (see above). This may apply also to highly lipophilic, halogenated BPA derivatives such as tetrabromobisphenol A (TBBA) one of today's most abundantly used brominated flame retardants. Indeed, it has been shown that in mice fed with 100 mg TBBA/kg body weight TBBA accumulates over-proportionally in the striatum compared with other brain regions (Nakajima et al., 2009 ).
The toxicity of BPA has been evaluated with respect to development, reproduction, and cancer (see, e.g., Xu et al., 2010; Fernandez et al., 2012) . In this context, a recent Food and Drug Administration update points to "some concern about the potential effect (of BPA) on the brain, behavior and prostate gland in fetuses, infants, and young children" (for review see Wolstenholme et al., 2011) . The BPA concentration administered in toxicological studies is expected to result in micromolar concentrations in different compartments of the body and should critically depend on BPA metabolism. Exact values in humans, however, are currently not available.
Given the fact that BPA and its related compounds are ubiquitously contaminating our environment, we expect that further studies will surface that medical diseases such as cardiovascular, respiratory, and metabolically caused disorders can at least partly be attributed to the effect of BPA on voltage-activated Ca 21 channels. Our findings that certain BPA-related compounds are less or even non-effective on voltage-activated Ca 21 channels may provide a key to finding molecules that could substitute for BPA in large-scale plastic production. 
